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Abstract
Background: The goal when resuscitating trauma patients is to achieve adequate tissue perfusion. One parameter of 
tissue perfusion is tissue oxygen saturation (StO2), as measured by near infrared spectroscopy. Using a commercially 
available device, we investigated whether clinically relevant blood loss of 500 ml in healthy volunteers can be detected 
by changes in StO2 after a standardized ischemic event.
Methods: We performed occlusion of the brachial artery for 3 minutes in 20 healthy female blood donors before and 
after blood donation. StO2 and total oxygenated tissue hemoglobin (O2Hb) were measured continuously at the thenar 
eminence. 10 healthy volunteers were assessed in the same way, to examine whether repeated vascular occlusion 
without blood donation exhibits time dependent effects.
Results: Blood donation caused a substantial decrease in systolic blood pressure, but did not affect resting StO2 and 
O2Hb values. No changes were measured in the blood donor group in the reaction to the vascular occlusion test, but in 
the control group there was an increase in the O2Hb rate of recovery during the reperfusion phase.
Conclusion: StO2 measured at the thenar eminence seems to be insensitive to blood loss of 500 ml in this setting. 
Probably blood loss greater than this might lead to detectable changes guiding the treating physician. The exact cut 
off for detectable changes and the time effect on repeated vascular occlusion tests should be explored further. Until 
now no such data exist.
Introduction
The goal of resuscitation is to achieve adequate tissue
perfusion. The patient's history, ongoing bleeding and
clinical signs of hypovolemia are the first trigger for vol-
ume substitution. Tissue perfusion is conventionally
monitored using arterial base deficit and serum lactate,
but these laboratory parameters are not always immedi-
ately available at the point-of-care. Additionally, relevant
blood loss may not be detected by conventional hemody-
namic monitoring [1].
Therefore, in the trauma setting, there is growing inter-
est in non-invasive techniques measuring tissue perfu-
sion. Near infrared spectroscopy (NIRS) has become a
widely used method for tissue hemoglobin oxygen satura-
tion (StO2) measurement in muscle and has been vali-
dated in animals [2-4] and in humans [5-11].
NIRS uses light with a wavelength of 650-950 nm and
easily crosses biological tissues. Near infrared light is
mainly absorbed by hemoglobin and only monitors ves-
sels with a diameter <1 mm, because the blood levels in
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larger vessels are too high to reflect enough light [12]. In
this setting, NIRS measurements primarily indicate the
venous oxyhemoglobin concentration, as only 20% of
blood volume is arterial and the NIRS device does not
differentiate between systole and diastole [13].
NIRS can be used to observe the microcirculatory reac-
tivity of peripheral tissue after a standardized ischemic
event. It has been shown that StO2 recovery after tran-
sient occlusion of the brachial artery differs in hemody-
namically unstable trauma patients in comparison to
healthy volunteers [14]. The StO2 response after a vascu-
lar occlusion test is an example of functional hemody-
namic monitoring, in which the response of the specific
system to a pre-determined stress is the monitored vari-
able. After induction of an artificial ischemic stress, local
metabolic demand and reperfusion reserve can be
assessed from the changes in parameters [14].
The aim of this study was to investigate the impact of a
controlled and clinically relevant blood loss (500 ml) on
resting StO2 values, as well as microcirculatory reactivity
triggered by a vascular occlusion test in healthy blood
donors. 500 ml of blood donation correspond to a loss of
10% of the whole blood volume. 10% of blood loss is con-
sidered to be the cut off for clinical relevant blood loss
according to the current literature and may become rele-
vant if pre- existing morbidity exists. For example, post-
partum hemorrhage, defined as blood loss more than 500
ml after a vaginal delivery, is a major cause of maternal
morbidity and mortality [15]. Other authors have been
able to detect 500 ml of blood loss with NIRS in various
settings [16,17].
We have decided to investigate the 500 ml blood loss
because of the controlled and safe study setting and
because higher blood volume losses are anyway related
with detectable changes in physiological parameters (e.g.
blood pressure, pulse rate). For the clinician, "borderline"
patients without obvious signs of blood loss present the
greater challenge.
We hypothesized that NIRS after a vascular occlusion
test would be able to detect this amount of blood loss,
because of the industries promise of "earliest" detection
of volume depletion.
Methods
Volunteers
We investigated 20 healthy female blood donors and 10
healthy female medical students as control subjects. The
study was restricted to women, as they have lower body
mass index (BMI) than men and are therefore more prone
to show slight symptoms of hypovolemia after blood
donation.
Blood donors had a median age of 30.5 y (range 19 - 62).
Their BMI was 21 kg/m2 median (range 18 - 23.5). The
median blood volume is estimated as 70 ml/kg body
weight or 4060 ml (range 3500 - 4550). The median capil-
lary hemoglobin was 139 g/l (range 127 - 157). This was
measured once immediately after arrival at the blood
donation service.
In the control group, the median age was 23 y (range 22
- 25). The median BMI was 21 kg/m2 (range 19 - 23). The
median blood volume was 4165 ml (range 3500 - 4480).
Protocol
Blood donors and control subjects were in a zero degree
supine position during the whole test. In both groups,
there was a resting period of 5 minutes before applying
the probe and performing the vascular occlusion test
measurement. We measured blood pressure manually
before every vascular occlusion test, using the same
sphygmomanometer cuff as when occluding the artery.
Blood donation started after a recovery period of 5 min-
utes. The second vascular occlusion test in the blood
donor group started immediately after the end of blood
donation.
In the control group, measurements were performed in
exactly the same way as in the blood donor group. In
order to detect a possible time effect from the vascular
occlusion tests, a 19-minute rest period was maintained
between the two vascular occlusion tests of the control
group. (Fig. 1) These 19 minutes are a median (range 14 -
22 minutes) measured in the blood donor group between
the end of the first and the start of the second vascular
occlusion test. This period included the recovery from
the first vascular occlusion, the preparation for phlebot-
omy and the actual blood donation, which lasted 11 min-
utes (range 9 - 13).
As this was an observational study aimed at controlling
the quality of a freely available device, and because no
additional data were collected from the volunteers, no
formal ethical approval was necessary, according to our
local ethical committee. Additionally, the vascular occlu-
sion using a cuff pressure of 50 mmHg above systolic
blood pressure, correlates to cuff pressures reached in
non invasive (Riva Rocci) blood pressure measurement.
Because no data on ethical considerations related to such
kind of setting have been available, AKE and VJ have
acted as volunteers. The discomfort has been within the
usual limits of blood pressure measurement and was later
very well tolerated by the volunteers and did not cause
any discomfort.
Measurements
We measured StO2 at the thenar eminence (opposite to
the blood donating arm) with a commercially available
tissue spectrometer (InSpectra® Model 650, Hutchinson
Technology, Hutchinson, Minn. US), which is promoted
as being able to detect blood loss in an emergency settingJeger et al. Journal of Trauma Management & Outcomes 2010, 4:5
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[18]. The method has been previously validated [19]. The
probe spacing was 15 mm.
The device measures and records StO2  and tissue
hemoglobin index (THI) every two seconds. THI is a
quantitative estimation of tissue hemoglobin concentra-
tion [20]. From these values, oxygenated hemoglobin
(O2Hb) was obtained by multiplying StO2  and THI,
because  [19]. Accordingly, the
amount of deoxygenated hemoglobin (HHb) equals the
residual hemoglobin: THI - O2Hb = HHb. W e defined
baseline variables before starting a vascular occlusion test
as the median over 2 minutes for StO2, O2Hb, and HHb.
A vascular occlusion test was performed by inflating
the sphygmomanometer cuff for 3 minutes with a pres-
sure of 50 mmHg over systolic BP as described in detail
by Creteur et al. [12]. The rate of decrease was calculated
from the linear part of the decrease (first 25%) after cuff
inflation [14]. The rate of recovery of StO2 and O2Hb was
defined over a mean of 14 seconds (8 data points) follow-
ing the nadir StO2 and O2Hb value at the end of ischemia.
Delta StO2 and delta O2Hb are defined as the difference
between the maximal value after reperfusion and the
baseline [12]. (Fig. 2, Fig. 3)
Data processing
Prism 5 (GraphPad Software, Inc., San Diego, CA, USA)
was used to calculate the statistics. Non-parametric tests
were used (Wilcoxon rank sum test for within-group dif-
ferences, Mann-Whitney U-test for between-group dif-
ferences). Data is presented as medians and interquartile
ranges. P-values have been interpreted in an exploratory
fashion.
Results
There was a markedly decrease in systolic blood pressure
in both groups before and after blood donation. Systolic
StO
OH b
O Hb HHb 2
2
2
= +
Figure 1 Time axis showing course of events for both groups.
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Figure 2 Typical StO2-trace of a blood donor. Whole length of re-
corded trace showing all events: 1st vascular occlusion test, recovery 
period, blood donation and 2nd vascular occlusion test. Details of a vas-
cular occlusion test are described in figure 3.
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blood pressure decreased from 118 mmHg median (inter-
quartile range: 118 - 123) to 110 mmHg (106 - 115) (p <
0.001) in the donor group and from 112 mmHg (103 -
118) to 106 mmHg (100 - 111) (p = 0.02) in the control
group. Systolic blood pressure decreased markedly more
in the donor group than in the control group (p = 0.02).
(Fig. 4)
For variables measured with NIRS, the differences from
the first to the second vascular occlusion test did not dif-
fer between the two groups. The only exception was the
differences in O2Hb 2 min median, which was slightly
larger in the control group -0.4 (-1.0 - -0.3) than in the
blood donor group -0.1 (-0.4 - 0.3) (p = 0.03). Therefore
the two groups are considered to be similar and compara-
ble.
StO2 and O2Hb 2 min median did not change substan-
tially in the blood donor group before and after blood
donation, but decreased in the control group after the
rest period: StO2 2 min median decreased from 82.0%
(79.5 - 85.0) to 80.5% (76.8 - 83.8) (p = 0.02), O2Hb 2 min
median decreased from 10.9 (9.6 - 12.4) to 10.2 (9.4 -
11.8) (p = 0.03). HHb 2 min median did not change in the
blood donor group, but increased in the control group
markedly from 2.35 (2.08 - 2.56) to 2.45 (2.20 - 2.92) (p =
0.01) (Table 1).
Variables measured during the vascular occlusion test
did not change in the blood donor group: The rate of
decrease, rate of recovery and delta for StO2 and O2Hb
did not show any substantial difference before and after
blood donation. In the control group, StO2 variables did
not change markedly - in contrast to the O2Hb values.
O2Hb rate of decrease was less steep after the rest period
(before: -0.039 (-0.051 - -0.026); after: -0.031 (-0.046 - -
0.020); p < 0.01), whereas O2Hb rate of recovery (before:
0.49 (0.39 - 0.63); after: 0.54 (0.39 - 0.69); p = 0.05) and
O2Hb delta (before: 3.88 (2.43 - 4.20); after: 4.0 (3.32 -
5.72); p = 0.01) increased after the rest period (Table 2).
Discussion
The principal finding of this study is, that although sys-
tolic blood pressure decreased substantially, blood loss
had no effect on superficial thenar StO2 before and after
blood donation measured by NIRS. However other
experimental NIRS devices have been successfully used
to monitor blood loss after blood donation. Torella et al.
showed that even 2% blood volume loss reduced periph-
eral hemoglobin oxygen saturation (PsO2, calf) signifi-
cantly [16]. Soller et al. simulated hypovolemia using
progressive lower body negative pressure and showed
that hypovolemia corresponding to 400 - 500 ml of blood
loss resulted in a decrease in forearm muscle oxygen satu-
ration [17]. The same group could also show, in the same
setting, that deep muscle oxygen saturation is more sensi-
tive in detecting hypovolemia (experimental NIRS
device) than superficial thenar StO2 (Hutchinson) [21].
Soller et al. discussed, that the location of the NIRS sen-
sor as well as the tissue depth might be responsible for
variations in results, although the technique used by the
two devices is in principle the same. We did use exactly
Figure 3 Focus on the reaction of a StO2-trace after a vascular oc-
clusion test. Δ: delta, difference between StO2max and StO2 baseline; 
rate of decrease (first 25%); rate of recovery.
rate of recovery
rate of
decrease

3 min ischemia
Figure 4 Scatter plot showing comparison of difference in systol-
ic blood pressure before and after blood donation (donor group) 
or before and after the rest period (control group). Line indicates 
median difference. p = 0.02.
Difference systolic blood pressure
blood donor vs control
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Table 1: NIRS variables and systolic blood pressure before each vascular occlusion test.
Blood donors Before blood donation After blood donation
median IQR median IQR two-tailed p-
value
StO2 79.0 74.5 - 83.5 78.5 75.0 - 83.0 0.34
O2Hb 10.7 9.3 - 11.9 10.8 8.9 - 11.7 0.43
deoxy Hb 2.62 2.39 - 3.24 2.70 2.34 - 4.39 0.30
SBP 118 118 - 123 110 106 - 115 <0.001*
Control Before rest period After rest period (19 minutes)
median IQR median IQR two-tailed p-
value
StO2 82.0 79.5 - 85.0 80.5 76.8 - 83.8 <0.05*
O2Hb 10.9 9.6 - 12.4 10.2 9.4 - 11.8 <0.05*
deoxy Hb 2.35 2.08 - 2.56 2.45 2.20 - 2.92 <0.01*
SBP 112 103 - 118 106 100 - 111 <0.05*
IQR: interquartile range, *: p < 0.05
Table 2: NIRS variables during the vascular occlusion tests.
Blood donors Before blood donation After blood donation
median IQR median IQR two-tailed 
p-value
StO2 rate of decrease(%/sec) -0.19 -0.21 - -0.16 -0.19 -0.23 - -0.15 0.78
StO2 rate of recovery (%/sec) 3.04 2.57 - 3.45 3.29 2.79 - 3.48 0.25
StO2 delta (%) 14.0 12.0 - 15.8 13.5 12.0 - 18.0 0.36
O2Hb rate of decrease (/sec) -0.033 -0.043 - -0.026 -0.027 -0.055 - -0.021 0.98
O2Hb rate of recovery (/sec) 0.59 0.50 - 0.72 0.63 0.48 - 0.74 0.59
O2Hb delta 4.33 3.47 - 4.97 4.76 4.24 - 5.42 0.06
Control Before rest period After rest period (19 minutes)
median IQR median IQR two-tailed 
p-value
StO2 rate of decrease (%/sec) -0.17 -0.19 - -0.15 -0.15 -0.20 - -0.12 0.43
StO2 rate of recovery (%/sec) 2.64 2.00 - 2.88 2.43 2.00 - 3.47 0.29
StO2 delta (%) 12.5 11.3 - 13.3 13.5 11.5 - 15.25 0.10
O2Hb rate of decrease (/sec) -0.039 -0.051 - -0.026 -0.031 -0.046 - -0.020 <0.01*
O2Hb rate of recovery (/sec) 0.49 0.39 - 0.63 0.54 0.39 - 0.69 <0.05*
O2Hb delta 3.88 2.43 - 4.20 4.00 3.32 - 5.72 <0.01*
IQR: interquartile range, *: p < 0.05Jeger et al. Journal of Trauma Management & Outcomes 2010, 4:5
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the same superficial thenar StO2 probe from Hutchinson
as Soller in her study, which may explain why we did not
detect any changes in NIRS parameters following blood
loss.
A second finding of this study is that there might be an
intrinsic effect of repeated vascular occlusion tests on
O2Hb. This hypothesis is based on the increase in delta
O2Hb and O2Hb rate of recovery and a decrease in oxy-
gen consumption (O2H b  r a t e  o f  d e c r e a s e ) ,  w h i c h  w a s
measured in the control group but not in the blood donor
group. This could be explained if there is a time effect of
repeated vascular occlusion tests, designated as ischemic
preconditioning [22]. This improves the ischemic toler-
ance of various tissues, including skeletal muscle, after
one or more brief periods of ischemia, each followed by a
short reperfusion phase. The underlying mechanisms are
still not clear. One reason may be the reduction in the
resting rate of oxygen consumption [23]. Although blood
loss does not result in different StO2 or O2Hb variables
after the vascular occlusion test, it seems to mask the
effect of ischemic preconditioning in the blood donor
group.
Limitations
One limitation with our paper is the assumption that
withdrawel of 500 ml of blood in a healthy volunteer rep-
resents a clinically relevant blood loss. Anyhow 10% of
circulating blood volume can not be neglected.
In addition we did not supply data on base excess and/
or lactate, the two parameters which are conventionally
used to estimate tissue oxygenation. This would have
helped to indicate whether a 500 ml blood loss was
indeed relevant, but was not feasible in the giving setting
of volunteer blood donation. Therefore, it is unclear as to
whether the device failed to identify tissue ischemia com-
pletely, which is unlikely as the values decreased during
vascular occlusion, or more likely, that no ischemia devel-
oped during blood donation.
Conclusion
StO2 measured at the thenar eminence seems to be insen-
sitive to blood loss of 500 ml in this setting. Probably
blood loss greater than this might lead to detectable
changes guiding the treating physician. The exact cut off
for detectable changes and the time effect on repeated
vascular occlusion tests should be explored further. Until
now no such data exist. Finally, our findings suggest that
StO2 measured by NIRS is not able to detect acute blood
loss of 500 ml and therefore, it might not be useful to
apply this device in the acute assessment of a bleeding
trauma patient. However, the device could help to iden-
tify hemodynamic worsening during the ICU stay but at
the moment not enough evidence exists to support this
hypothesis.
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